Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.45 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | THPO | P40225 | 1/20 | 0.42 |
| ▸ | MTOR | P42345 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CETP | P11597 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | UBE2N | P61088 | 1/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.41 |
| ▸ | FDPS | P14324 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1023184 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL7119558 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL20477538 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL7993815 | 1.00 | GPR84 (0.45) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL7119131 | 0.98 | GPR84 (0.41) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL9732333 | 0.90 | ALDH1A1 (0.37) | GPR84SPHK1FFAR1LMNAFDPS | |
| SCHEMBL30874780 | 0.80 | GPR84 (0.48) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| SCHEMBL30262990 | 0.80 | GPR84 (0.48) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| Ammonia Solution, Strong SCHEMBL9635696 | 0.79 | GPR84 (0.39) | GPR84SPHK1FFAR1LMNACYP2D6 | |
| Ammonia Solution, Strong SCHEMBL28834637 | 0.79 | GPR84 (0.39) | GPR84SPHK1FFAR1LMNACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109134716-B | Vanadium catalyst and method for preparing olefin polymer | 北京引发科技有限公司 | 2020-11-10 | — | — | CN | claimed |
| CN-109134716-B | Vanadium catalyst and method for preparing olefin polymer | 北京引发科技有限公司 | 2020-11-10 | — | — | CN | disclosed |
| US-20030144541-A1 | Process for preparing alpha-halogenated retones | RHODIA CHIMIE (FR) | 2003-07-31 | — | — | US | disclosed |
| EP-1250303-A1 | METHOD FOR PREPARING ALPHA-HALOGENATED KETONES | RHODIA CHIMIE (FR) | 2002-10-23 | — | — | EP | disclosed |
| WO-2001055067-A1 | METHOD FOR PREPARING ALPHA-HALOGENATED KETONES | RHODIA CHIMIE (FR) | 2001-08-02 | — | — | WO | disclosed |
| US-5696087-A | ADMINISTERING A POLYPEPTIDE | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 1997-12-09 | — | — | US | disclosed |
| US-5681819-A | POLYPEPTIDE CONTAINING ATLEAST 4 ELEVEN AMINO ACID REPEAT HAVING ATLEAST THREE PROLINES PRESENT IN CARBOXY TERMINAL REGION OF HUMAN BILE SALT ACTIVATED LIPASE, THAT BINDS SPECIFIC RECEPTOR ON INTESTINAL CELL | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 1997-10-28 | — | — | US | disclosed |
| EP-0795011-A1 | METHOD AND COMPOSITIONS FOR REDUCING CHOLESTEROL ABSORPTION | Oklahoma Medical Research Foundation (US) | 1997-09-17 | — | — | EP | disclosed |
| WO-1996017054-A1 | METHOD AND COMPOSITIONS FOR REDUCING CHOLESTEROL ABSORPTION | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 1996-06-06 | — | — | WO | disclosed |
| US-5270334-A | 4-methoxy-5-methyl-pyran-3-ol natural products and derivatives thereof | E. R. SQUIBB & SONS, INC. (US) | 1993-12-14 | — | — | US | disclosed |
| US-5248790-A | Antibiotics | E. R. SQUIBB & SONS, INC. (US) | 1993-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030144541-A1 | Process for preparing alpha-halogenated retones | ADH1A, ADH1C, RER1 | GPR84 1884/4885SPHK1 2673/4885FFAR1 1333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.